UNSPSC 51111860: Mitotane

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51111860

Definition

This classification denotes an anti-adrenal with the molecular formula C14H10Cl4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 78E4J5IB5J, chemically known as 2,4-dichlorophenyldichlorethane but generally known as mitotane, which bears US NIH Compound Identifier 4211. European Medicines Agency schedules Mitotane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09010MIG.

Read the full definition

The term MITOTANE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules mitotane in its Anatomical Therapeutic Chemical (ATC) Classification. MITOTANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, MITOTANE remains the US FDA Preferred Term for this commodity. Mitotane bears US NLM identifiers UMLS ID C0026256 and NCI Concept Code C664. SMILES: CLC(CL)C(C1CCC(CL)CC1)C1C(CL)CCCC1.

About UNSPSC 51111860

UNSPSC 51111860 Mitotane is a Commodity code covering the pharmaceutical product mitotane, an adrenolytic agent used primarily in the treatment of adrenocortical carcinoma. State and local governments procure mitotane through their health departments, public health agencies, and institutional pharmacy systems to support cancer treatment protocols at state and county hospitals, correctional facilities, and public health clinics. The drug is typically acquired through competitive bid processes, cooperative purchasing agreements, or standing contracts negotiated by state pharmaceutical benefit managers or group purchasing organizations. Mitotane procurement is driven by clinical demand rather than routine volume — usage patterns reflect the low incidence of adrenocortical carcinoma in the general population, making this a specialty pharmaceutical code with episodic purchasing activity across most jurisdictions.

The source provided contains no recent state or local contract opportunities for mitotane. Without documented solicitations, geographic concentration and issuing-body patterns cannot be characterized from current market activity. Procurement under this code is likely distributed across state health departments and institutional pharmacy networks wherever adrenocortical carcinoma treatment occurs, but the absence of posted opportunities suggests either that mitotane is acquired through standing state contracts, cooperative purchasing vehicles, or direct manufacturer relationships rather than competitive solicitations, or that activity is too sparse to generate public notice records during the current period.

Quick answers

What is UNSPSC 51111860?

UNSPSC 51111860 is Mitotane, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51111860?

UNSPSC 51111860 maps to 1 NIGP code, 26968 Hormones and Synthetic Substitutes.

On GovTribe

See everything under UNSPSC 51111860

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code